Literature DB >> 16362179

DDAVP use in patients undergoing transsphenoidal surgery for pituitary adenomas.

J M Sheehan1, J P Sheehan, G L Douds, R B Page.   

Abstract

BACKGROUND: Disorders of fluid and sodium regulation, often termed "diabetes insipidus," are a frequent occurrence following surgery for pituitary adenomas. The present study was undertaken to identify the incidence of diabetes insipidus after pituitary surgery and its associated factors.
METHODS: A retrospective review of the medical records 300 patients who underwent transsphenoidal surgery for pituitary adenoma was undertaken. Information regarding patient gender, perioperative serum sodium levels and urinary output volumes, tumor size, previous pituitary surgery, tumor subtype, and the use of DDAVP was gathered. A multivariate statistical analysis was performed.
FINDINGS: Follow-up data were available on 288 patients. During the inpatient postoperative hospital stay, DDAVP was administered to 19% of all patients and 16% of patients not taking DDAVP preoperatively. Of patients with normal fluid/sodium regulation preoperatively, DDAVP was prescribed for 9% at discharge and 4% at 6 weeks postoperatively. Only 1.4% of patients were taking vasopressing replacement at the time of last follow-up. Significant correlations were found between gender, previous surgery, serum sodium levels, and urine volumes at various time points. Immunohistochemical type of tumor and tumor size were not related to DDAVP requirement.
CONCLUSIONS: Transient hypotonic polyuria is frequently encountered after pituitary surgery. However, only a small number of patients will develop a long-term requiring for ongoing medical treatment. Previous surgery, female gender, and elevated serum sodium and urine volumes in perioperative period were associated with DDAVP requirement.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16362179     DOI: 10.1007/s00701-005-0686-0

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  9 in total

Review 1.  Hyponatraemia and hypernatraemia: Disorders of Water Balance in Neurosurgery.

Authors:  Mendel Castle-Kirszbaum; Mervyn Kyi; Christopher Wright; Tony Goldschlager; R Andrew Danks; W Geoffrey Parkin
Journal:  Neurosurg Rev       Date:  2021-01-03       Impact factor: 3.042

2.  Change in cephalocaudal tumor cavity diameter after transsphenoidal surgery is a predictor of diabetes insipidus in pituitary adenoma.

Authors:  Kunzhe Lin; Kaichun Fan; Shuwen Mu; Shousen Wang
Journal:  Eur J Med Res       Date:  2022-05-25       Impact factor: 4.981

3.  Post-operative diabetes insipidus after endoscopic transsphenoidal surgery.

Authors:  Matthew Schreckinger; Blake Walker; Jordan Knepper; Mark Hornyak; David Hong; Jung-Min Kim; Adam Folbe; Murali Guthikonda; Sandeep Mittal; Nicholas J Szerlip
Journal:  Pituitary       Date:  2013-12       Impact factor: 4.107

4.  Diabetes Insipidus following Endoscopic Transsphenoidal Surgery for Pituitary Adenoma.

Authors:  Abdulrazag M Ajlan; Sarah Bin Abdulqader; Achal S Achrol; Yousef Aljamaan; Abdullah H Feroze; Laurence Katznelson; Griffith R Harsh
Journal:  J Neurol Surg B Skull Base       Date:  2017-08-03

Review 5.  Postoperative assessment of the patient after transsphenoidal pituitary surgery.

Authors:  John C Ausiello; Jeffrey N Bruce; Pamela U Freda
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

6.  Hypothalamus-Pituitary Dysfunction as an Independent Risk Factor for Postoperative Central Nervous System Infections in Patients With Sellar Region Tumors.

Authors:  Junxian Wen; Rui Yin; Yihao Chen; Jianbo Chang; Baitao Ma; Wei Zuo; Xiao Zhang; Xiaojun Ma; Ming Feng; Renzhi Wang; Wenbin Ma; Junji Wei
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-30       Impact factor: 5.555

7.  Safety and cost effectiveness of early discharge following microscopic trans-sphenoidal resection of pituitary lesions.

Authors:  Jonathan A Forbes; Jani Wilkerson; Lola Chambless; Sheila D Shay; Clay M Elswick; Parker W Abblitt; Owoicho Adogwa; Paul Russell; Kyle D Weaver; George S Allen; Andrea L Utz
Journal:  Surg Neurol Int       Date:  2011-05-28

8.  Curative effects of head γ-SRT for the treatment of functional pituitary macroadenoma.

Authors:  Wei Lian; Ren Zhi Wang; Bing Xing; Yong Yao
Journal:  Oncol Lett       Date:  2016-06-14       Impact factor: 2.967

9.  Factors Associated with Postoperative Diabetes Insipidus after Pituitary Surgery.

Authors:  Antonio L Faltado; Anna Angelica Macalalad-Josue; Ralph Jason S Li; John Paul M Quisumbing; Marc Gregory Y Yu; Cecilia A Jimeno
Journal:  Endocrinol Metab (Seoul)       Date:  2017-11-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.